5-Fluorouracil Administered as a 48-Hour Semiintermittent Infusion in Combination with Leucovorin, Cisplatin and Epirubicin: Phase II Study in Advanced Gastric Cancer Patients

Giacomo Allegrini, Alfredo Falcone, Roberta Di Marsico, Monica Lencioni, Gianluca Masi, Costanza Galli, Samanta Cupini, Elisabetta Pfanner, Lorenzo Marcucci, Pier Franco Conte

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '5-Fluorouracil Administered as a 48-Hour Semiintermittent Infusion in Combination with Leucovorin, Cisplatin and Epirubicin: Phase II Study in Advanced Gastric Cancer Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences